Tristel PLC
LSE:TSTL

Watchlist Manager
Tristel PLC Logo
Tristel PLC
LSE:TSTL
Watchlist
Price: 429 GBX 0.94% Market Closed
Market Cap: 204.6m GBX
Have any thoughts about
Tristel PLC?
Write Note

Tristel PLC
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Tristel PLC
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Tristel PLC
LSE:TSTL
Current Portion of Long-Term Debt
ÂŁ814k
CAGR 3-Years
-2%
CAGR 5-Years
N/A
CAGR 10-Years
30%
Abingdon Health PLC
LSE:ABDX
Current Portion of Long-Term Debt
ÂŁ87k
CAGR 3-Years
-71%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
ConvaTec Group PLC
LSE:CTEC
Current Portion of Long-Term Debt
$20.7m
CAGR 3-Years
-42%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Inspecs Group PLC
LSE:SPEC
Current Portion of Long-Term Debt
ÂŁ13m
CAGR 3-Years
24%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Advanced Medical Solutions Group PLC
LSE:AMS
Current Portion of Long-Term Debt
ÂŁ1.5m
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Rua Life Sciences PLC
LSE:RUA
Current Portion of Long-Term Debt
ÂŁ117k
CAGR 3-Years
25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Tristel PLC
Glance View

Market Cap
203.3m GBX
Industry
Health Care

Tristel Plc engages in the design, development, manufacture, and sale of infection control, contamination control and hygiene products. The company is headquartered in Snailwell, Cambridgeshire and currently employs 189 full-time employees. The company went IPO on 2005-06-01. The Company’s technology is a chlorine dioxide formulation used by hospitals for the high-level disinfection of medical devices and the sporicidal disinfection of environmental surfaces. The Company’s segments include Hospital medical device decontamination and Hospital environmental surface disinfection. The firm manufactures and sells medical device decontamination products that are used primarily for infection control in hospitals. The firm also manufactures and sells hospital environmental surface disinfection products. The Tristel brand offers airway management, cardiology, ear, nose and throat, ophthalmology, endoscopy, phlebotomy, surfaces, ultrasound, urology, and women's health. The Crystel brand offers pharmaceutical, cosmetic and toiletry (PCT), cleanroom disinfectants and laboratory disinfectants. The company markets its products under the Tristel, Anistel, and Crystel brands.

TSTL Intrinsic Value
422.12 GBX
Overvaluation 2%
Intrinsic Value
Price

See Also

What is Tristel PLC's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
814k GBP

Based on the financial report for Dec 31, 2023, Tristel PLC's Current Portion of Long-Term Debt amounts to 814k GBP.

What is Tristel PLC's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 10Y
30%

Over the last year, the Current Portion of Long-Term Debt growth was -2%. The average annual Current Portion of Long-Term Debt growth rates for Tristel PLC have been -2% over the past three years , and 30% over the past ten years .

Back to Top